Principal Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
6,600
+1,137
| +21% | +$506K | 0.06% | 309 |
|
|
2025
Q1 | $2.2M | Hold |
5,463
| – | – | 0.05% | 330 |
|
|
2024
Q4 | $2.2M | Buy |
5,463
+1,164
| +27% | +$469K | 0.05% | 327 |
|
|
2024
Q3 | $2M | Buy |
4,299
+226
| +6% | +$105K | 0.05% | 348 |
|
|
2024
Q2 | $1.91M | Buy |
4,073
+1,127
| +38% | +$528K | 0.05% | 312 |
|
|
2024
Q1 | $1.23M | Buy |
2,946
+582
| +25% | +$243K | 0.04% | 397 |
|
|
2023
Q4 | $962K | Buy |
+2,364
| New | +$962K | 0.04% | 422 |
|